14-35085605-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The ENST00000261475.10(PPP2R3C):c.1347C>A(p.Asp449Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,609,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000261475.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP2R3C | NM_017917.4 | c.1347C>A | p.Asp449Glu | missense_variant | 13/13 | ENST00000261475.10 | NP_060387.2 | |
LOC101927178 | NR_110415.1 | n.479+4046G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP2R3C | ENST00000261475.10 | c.1347C>A | p.Asp449Glu | missense_variant | 13/13 | 1 | NM_017917.4 | ENSP00000261475 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000928 AC: 23AN: 247742Hom.: 0 AF XY: 0.0000896 AC XY: 12AN XY: 133902
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1457312Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 12AN XY: 724924
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.1347C>A (p.D449E) alteration is located in exon 13 (coding exon 13) of the PPP2R3C gene. This alteration results from a C to A substitution at nucleotide position 1347, causing the aspartic acid (D) at amino acid position 449 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at